Darling Ingredients' Rousselot has announced receipt of US patent for StabiCaps gelatin technology


Rousselot, a health brand of Darling Ingredients, has been granted a U.S. Patent and Trademark Office Patent No. UA11795489B2 for its StabiCaps product.

Photo © Shutterstock.com/jovan vitanovski

Photo © Shutterstock.com/jovan vitanovski

Rousselot, a health brand of Darling Ingredients (Irving, CA), has been granted a U.S. Patent and Trademark Office Patent No. UA11795489B2, securing the intellectual property rights for StabiCaps, which is a specialized gelatin that improves the formulation and stability of soft gel capsules by addressing crosslinking. The company explains in a press release that crosslinking happens when the soft gels are exposed to specific active compounds or poor storage conditions to cause molecular bonds within the capsule shell that limit or prevent dissolution of the capsule.

“StabiCaps is an essential innovation for soft gel manufacturers because gelatin is a primary ingredient,” said Pierre-Albert Thomas, Rousselot Functional Ingredients Director, in a press release. “With this new patent, soft gel manufacturers in the U.S. can unlock the benefits of StabiCaps gelatin technology to produce high-quality soft gels with longer shelf stability and improved efficacy for customers.”

Related Videos
woman working on laptop computer by window
© 2024 MJH Life Sciences

All rights reserved.